Eraquel Horse Wormer Tablets
You will be required to submit a POM-VPS form with this product at the checkout to enable completion of your order.
Note: Currently not available for delivery to Northern Ireland, Channel Islands, Ireland Republic, EU 1, EU 2, EU 3, EU 4, EU 5, EU 6, EU 7, EU 8, Global 1 and USA.
Eraquel Horse Wormer Tablets for the treatment and control of adult and immature gastrointestinal roundworms, lungworms and bots of horses.
Use of a scale or weigh tape is recommended to ensure accurate dosage.
Link to Veterinary Medicines Suspected Adverse Reaction Scheme
To ensure that you read the most up to date product information link to http://www.vmd.defra.gov.uk/ProductInformationDatabase/Search.aspx
Presentation
White, circular, biconcave tablet with brown spots.
Each chewable tablet of 3300mg contains 20mg ivermectin.
Contra-indications, warnings, etc
Do not use in foals under 2 weeks of age. Do not use in horses known to be hypersensitive to the active ingredient or any of the other ingredients.
Colic, diarrhoea and anorexia have been reported in very rare occasions post treatment, in particular when there is heavy worm burden. In very rare occasions, allergic reactions such as hypersalivation, lingual oedema, urticaria, tachycardia, congested mucus membranes, and subcutaneous oedema have been reported following treatment with the product.
Special precautions for use in animals
Avermectins may not be well tolerated in non target species. Cases of intolerance are reported in dogs, especially Collies, Old English Sheepdogs and related breeds or crosses, and also in turtles and tortoises.
Dogs and cats should not be allowed to ingest spilled tablet or have access to used packaging due to the potential for adverse effects related to ivermectin toxicity.
Young foals, miniature horses and toy breeds weighing less than 50 kg may be unable to ingest tablets. Seek the advice of your veterinary surgeon.
Special precautions to be taken by the person administering the veterinary medicinal product to animals
Wash hands after use. Avoid contact with the eyes. In case of eye irritation, seek medical attention. Do not eat, drink or smoke while handling this product. In the event of accidental ingestion, seek medical advice and show the leaflet to the physician so that he knows what you have taken.
Special warnings for target species
Care should be taken to avoid the following practices because they increase the risk of development of resistance and could ultimately result in ineffective therapy: too frequent and repeated use of anthelmintics from the same class over an extended period of time, underdosing, which may be due to underestimation of body weight, misadministration of the product, or lack of calibration of the dosing device (if any).
Suspected clinical cases of resistance to anthelmintics should be further investigated using appropriate tests (e.g. Faecal Egg Count Reduction Test). Where the results of the test(s) strongly suggest resistance to a particular anthelmintic, an anthelmintic belonging to another pharmacological class and having a different mode of action should be used.
Resistance to ivermectin has been reported in Parascaris equorum in horses. Therefore the use of this product should be based on local (regional, farm) epidemiological information about susceptibility of nematodes and recommendations on how to limit further selection for resistance to anthelmintics.
The product is safe for use in stallions.
Overdose
A tolerance study performed with the product in adult horses with doses up to 5 times the recommended dosage did not show any adverse reactions.
Safety studies were conducted with a veterinary medicinal product containing praziquantel and the same dose of ivermectin (EQUIMAX oral gel), in mares, stallions and foals.
Administration to mares at 3 times the recommended dosage at 14-day intervals during the whole gestation and lactation periods did not result in any abortion, nor any adverse effect during gestation, at parturition or on the mares general health, nor any abnormality in the foals.
Administration to stallions at 3 times the recommended dosage did not show any adverse effect in particular on the reproductive performances.
Administration to foals with doses up to 5 times the recommended dosage did not show any adverse reaction.
Withdrawal period: Horses may be slaughtered for human consumption only after 35 days from the last treatment. Not to be used in horse producing milk for human consumption
Container disposal: Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements. EXTREMELY DANGEROUS TO FISH AND AQUATIC LIFE. Do not contaminate surface waters or ditches with the product or used container.
Further information
No known interaction with other equine medicaments.
Pharmaceutical precautions
This veterinary medicinal product does not require any special storage condition.
Do not use after the expiry date stated on the box.
Once opened, use the product within 12 months.
Keep out of the reach and sight of children.
Legal category: POM-VPS
Marketing Authorisation Number
Vm 05653/4159
GTIN description:Eraquell Tabs, tube of 8 tablets
GTIN:3597133054897
Collect in Store
This item is available for collection.